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Abstract
Backgound: Previous studies have shown that the functional capacity of T cells may be modulated
by the composition of fatty acids within, and the release of fatty acids from membrane
phospholipids, particulary containing arachidonic acid (AA). The remodeling of AA within
membrane phospholipids of resting and proliferating CD4+ and CD8+ T cells is examined in this
study.
Results: Splenic T cells were cultured in the presence or absence of anti-CD3 mAb for 48 h then
labeled with [3H]AA for 20 min. In unstimulated cells, labeled AA was preferentially incorporated
into the phosphoglycerides, phosphatidylcholine (PC) followed by phosphatidylinositol (PI) and
phosphatidylethanolamine  (PE). During a subsequent chase in unlabeled medium unstimulated
CD4+ and CD8+ T cells demonstrated a significant and highly selective transfer of free, labeled AA
into the PC pool. In contrast, proliferating CD4+ and CD8+ T cells distributed labeled [3H]AA
predominantly into PI followed by PC and PE. Following a chase in AA-free medium, a decline in
the content of [3H]AA-PC was observed in association with a comparable increase in [3H]AA-PE.
Subsequent studies revealed that the cold AA content of all PE species was increased in
proliferating T cells compared with that in non-cycling cells, but that enrichment in AA was
observed only in the ether lipid fractions. Finally, proliferating T cells preincubated with [3H]AA
exhibited a significant loss of labeled arachidonate in the PC fraction and an equivalent gain in
labeled AA in 1-alk-1'-enyl-2-arachidonoyl-PE during a chase in unlabeled medium.
Conclusion: This apparent unidirectional transfer of AA from PC to ether-containing PE suggests
the existence of a CoA-independent transacylase system in T cells and supports the hypothesis that
arachidonoyl phospholipid remodeling may play a role in the regulation of cellular proliferation.
Background
T lymhocytes occupy a pivotal role in immune regulation
by virtue of their ability to promote B cell maturation,
drive antibody production and influence the growth and
proliferation of macrophages, neutrophils, mast cells,
eosinophils and other T cells. Previous studies have
shown that the functional capacity of T cells may be mod-
ulated by the composition of fatty acids within, and the
release of fatty acids from membrane phospholipids.
Alterations in the content of membrane phospholipids,
particularly those containing arachidonic acid (AA) have
been shown to modify the cytotoxic capacity of T cells [1],
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membrane transport processes [2], enzymatic activity [3]
and the expression of programmed cell death [4]. AA pro-
motes the activation of protein kinase C [5], stimulates T
cell mitogenesis [6] and serves as a precursor of prostag-
landins and leukotrienes [3].
In T lymphocytes, which lack significant 5-lipoxygenase
and cyclooxygenase activities, the level of free arachidonic
acid (AA) is tightly regulated. AA comprises approxi-
mately 25% of fatty acids within the plasma membranes
of resting T cells [7]. It is found primarily esterified at the
sn-2 position of the phophoglycerides, phosphatidylcho-
line (PC), phosphatidylserine (PS), phosphatidylinositol
(PI) and phosphatidylethanolamine (PE). In unstimu-
lated T cells, PC and PE each contain approximately 38%,
PI 20% and PS 4% of the total AA content of plasma mem-
brane phospholipids. Less than 3% of AA exists free in T
cell membranes.
AA is introduced into phospholipid molecular species
largely after de novo synthesis, through remodeling path-
ways. The remodeling of arachidonoyl phospholipids is
orchestrated by acyltransferases and transacylases [8].
Acyl-CoA synthetase catalyzes the ATP-dependent produc-
tion of arachidonoyl-CoA. Acyl-CoA:lysophosphatidyl
acyltransferase may then transfer AA to the sn-2 position
of 1-acyl-glycerophospholipids. In resting lymph node T
cells, 1-acyl-PC is the preferred acceptor species [7].
Whether 1-acyl-, 1-alkyl- and 1-alk-1'enyl-lysophospholi-
pid acceptors require different acyltransferases in T cells is
currently unknown. Acyltransferase activities are thought
to be coupled to phospholipase A2, which generates lyso-
phospholipids thereby completing a deacylation-reacyla-
tion cycle. A number of reports have suggested that several
members of the phospholipase A2 family are capable of
exhibiting acyltransferase and transacylase activities in
membranes. In this connection, cytosolic phospholipase
A2, which is specific for AA-containing phospholipids, has
been shown to express both phospholipase A2 and lyso-
phospholipase/transacylase activities [9,10]. Thus, phos-
pholipase A2s may be important in the remodeling of AA-
containing phospholipids in certain cells with inflamma-
tory properties.
CoA-dependent transacylases provide another mecha-
nism by which AA esterified in phospholipids may be
transferred to lysophospholipids, in this case without the
generation of free fatty acids [11]. CoA-dependent transa-
cylation occurs in T cells in the absence of ATP and Mg2+
and may be mediated by the backward reaction of acyl-
CoA:lysophospholipid acyltransferase [7,12-14].
CoA-independent transacylase activity has been found in
cells that contain significant concentrations of ether-
linked phospholipids, such as macrophages and neu-
trophils [15,16]. This activity catalyzes the transfer of C20
and C22 polyunsaturated fatty acids from the sn-2 posi-
tion of diacylphospholipids to lysophospholipids in the
absence of CoA or other cofactors [4]. A preferred sub-
strate of CoA-independent transacylase is diacyl-PC [17].
Potential acceptor lysophospholipids include 1-alkenyl,
1-acyl and 1-alkyl species of both PC and PE [17,18].
The incorporation and distribution of AA in a variety of
cells with proinflammatory potential such as neutrophils,
macrophages and mast cells follows a predictable pattern.
As stated above, AA is initially incorporated into specific
phospholipids and subsequently remodeled under the
influence of acyl-CoA synthetase, acyl-CoA transferase
and acyltransferases. In such cells, the AA content of the
ether phospholipids, 1-alkyl-2-acyl-PC and 1-alk-1'-enyl-
2-acyl-PE is particularly high [17,19,20] and the arachido-
noyl plasmalogen pool increases further following activa-
tion [19,21-24]. It has been hypothesized [25] that these
ether phospholipids may serve as reservoirs for key lipid
mediators (e.g. platelet activating factor) and/or AA deriv-
atives (i.e. prostaglandins and leukotrienes). On the bases
of fatty acid and donor specificities, it has been suggested
further that the transfer of AA from 1-acyl-2-arachidonoyl-
PC to 1-alkyl-2-lyso-PC and 1-alk-1'-enyl-2-lyso-PE is
mediated by a CoA-independent transacylase activity
[8,25].
T cells possess certain biological and chemical similarities
with neutrophils, macrophages and mast cells in that they
have proinflammatory potential and contain relatively
high levels of ether phospholipids [19]. However, unlike
macrophages, neutrophils or mast cells resting T cells fail
to accumulate significant levels of ether-containing phos-
pholipids following short-term incubation with labeled
AA. This leaves open the question of whether a CoA-inde-
pendent transacylase system is a common feature of cells
with inflammatory properties, including those that pos-
sess a limited capacity to synthesize eicosanoids and
platelet activating factor, such as T cells. The issue is of
immunological interest since significant expression of
CoA-independent transacylase activity is in part a com-
mitment to the generation of plasmalogens, which may
play a role in T cell function. To test the hypothesis that T
cells possess CoA-independent transacylase activity in
vivo, we took advantage of the fact that the arachidonoyl-
phospholipid remodeling rate may be greatly accelerated
in proliferating cells. Our results suggest that proliferating
T cells possess a CoA-independent transacylase system as
evidenced by an apparent transfer of AA from diacyl-PC to
1-alk-1'-enyl-lyso-PE and support the hypothesis [25] that
the remodeling of AA-phospholipids and the generation
of plasmalogens play a possible role in cell growth.Lipids in Health and Disease 2004, 3 http://www.lipidworld.com/content/3/1/1
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Results and Discussion
[3H]AA incorporation, distribution and turnover in T cells 
stimulated with anti-CD3 mAb
Initial studies were directed toward comparing the distri-
bution of radioactive AA of high specific activity in prolif-
erating and resting T cells. The monoclonal anti-CD3
antibody was chosen as the stimulant. Anti-CD3 trans-
duces a signal that mimics antigen binding to the T cell
receptor. Preliminary experiments revealed that splenic T
cells activated with anti-CD3 mAb exhibited maximal tri-
tiated thymidine incorporation at 48 hrs [Fig 1, inset]. To
examine differences in the distribution of [3H]AA within
phosphoglycerides of cycling versus quiescent T lym-
phocytes, cells were cultured in the presence or absence of
anti-CD3 mAb for 48 hrs, then harvested, washed and
incubated with labeled arachidonate for up to 60 min. At
varying times, lipid extracts were prepared, phospholipids
were resolved by TLC and [3H]arachidonoyl-phospholi-
pid content within T cell membranes was quantified by
liquid scintillation counting. Optimal incorporation of
labeled material was found to occur in cultured cells at 20
min [Fig. 1]. At that time, 65.4 ± 3.2% of added label was
cell associated in unstimulated cells and 76.0 ± 4.5% in
proliferating T cells.
After 20 min. of culture, unstimulated cells preferentially
incorporated [3H]AA into PC followed by PI and PE [Fig.
2, left panel, 0 minute]. Approximately 20% of labeled AA
remained free in the membrane. In contrast, at 20 min
proliferating T cells distributed [3H]AA predominantly
into PI followed by PC and PE and showed an approxi-
mate 67% reduction in the level of free AA relative to
unstimulated T cells [Fig. 2, right panel, 0 minute]. Less
than 3% of [3H]AA was present in the PS fraction of both
proliferating and control T cells (not shown).
The cells were then washed and recultured in BME con-
taining 1% BSA for an additional 60 min. The molar
quantities of cold arachidonate and the radioactivity
within the total phosholipid pool did not significantly
change during the chase period (data not shown). Over
time, unstimulated T cells displayed a small but signifi-
cant decline in the level of free [3H]AA and an increase in
the level of [3H]AA-PC [Fig 2, left panel]. In proliferating
T cells, a marked decline in the content of [3H]AA-PC
(1.15 pmol/107 cells) was observed in association with an
increase in the level of [3H]AA-PE (1.22 pmol/107 cells)
when cells were chased for 60 min in AA-free medium [Fig
2, right panel].
[3H]AA incorporation into CD4+ and CD8+ T cell subsets
To determine whether the differences in [3H]AA distribu-
tion in proliferating versus unstimulated T cells was lim-
ited to a particular T cell subset, splenic CD4+ and CD8+ T
cells, negatively selected following a 48 hr culture in the
presence and absence of anti-CD3 mAb, were incubated
with [3H]AA for up to 20 min. The cells were then washed
and further cultured for 60 min, as above in BME with 1%
BSA. Membrane phospholipids were then extracted, sepa-
rated by TLC and radioactivity was quantified by liquid
scintillation counting. Proliferating CD4+  and CD8+  T
cells exhibited quantitatively similar reductions in the lev-
els of [3H]AA-PC and corresponding increases in those of
[3H]AA-PE over time [Fig. 3]. Because differences in ara-
chidonoyl-phospholipid remodeling were not apparent
between CD4+ and CD8+ T cells, subsequent experiments
were carried out using unfractionated T cells.
[3H]AA incorporation in T cells Figure 1
[3H]AA incorporation in T cells. Splenic T cells were cul-
tured for 48 hr with (open circles) or without (closed circles) 
anti-CD3 mAb, then incubated with [3H] AA (1 µCi/ml) for 
up to 60 min. At varying times, cells were harvested and 
labeled AA incorporation was quantified. Inset, Tritiated thy-
midine incorporation, assessed daily for 3 days, in T cells cul-
tured with (open circles) or without (closed circles) anti-
CD3 mAb. The results are the mean and standard error of 3 
separate experiments.Lipids in Health and Disease 2004, 3 http://www.lipidworld.com/content/3/1/1
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Arachidonic acid content in proliferating and resting T 
cells
We next compared the AA content in membrane phos-
phatides of proliferating and control T cells. Splenic T cells
were cultured with and without anti-CD3 mAb for 48 hr.
Membrane lipids were extracted, separated by TLC, glycer-
olipids were isolated, fatty acids were derivatized to
methyl esters and AA content was measured by gas chro-
matography. Relative to controls, proliferating cells dem-
onstrated a marked increase in AA-PE (9.5 nmol/107 cells)
The distribution and turnover of [3H]AA in proliferating and unstimulated T cells Figure 2
The distribution and turnover of [3H]AA in proliferating and unstimulated T cells. Splenic T cells, previously cultured as above 
for 48 hours with (right panel, open circles) or without (left panel, closed circles) anti-CD3 mAb, were labeled with [3H]AA (1 
µCi/ml) for 20 min at 37°C. The cells were then washed and cultured at 37°C for up to 60 min in BME with 1% BSA. At the ini-
tiation of culture (zero time) and at various times thereafter, cells were harvested, membrane lipids were extracted and free 
AA and phosphoglycerides were resolved by TLC. The concentration of free [3H]AA and of [3H]AA within different phosphol-
ipid molecular species was measured by liquid scintillation counting. Data are the mean and standard error of 4 separate 
experiments.Lipids in Health and Disease 2004, 3 http://www.lipidworld.com/content/3/1/1
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and a smaller increase in AA-PI (2.0 nmol/107cells) [Fig
4]. No significant differences were found in the levels of
arachidonoyl-PC and -PS.
Arachidonic acid content in diacyl and plasmalogen 
species of PC and PE
The AA content within individual species of PC and PE
was next determined in proliferating and control T cells.
Membrane glycerolipids of T cells previously cultured for
48 hr with anti-CD3 mAb or medium were resolved by
TLC, separated into diacyl-, 1-alkyl-2-acyl- and 1-alk-1'-
enyl-2-acyl-phospholipids and arachidonoyl-phospholi-
pid levels were quantified by gas chromatography. Equiv-
alent levels of arachidonate were found in individual
species of PC in proliferating and control T cells [Fig 5]. In
contrast, the AA content of all PE species was increased in
proliferating T cells compared with that in non-cycling
cells.
The changes in the individual species of PC and PE, which
accompany T cell proliferation were examined. After 48 hr
of culture with anti-CD3 mAb, a significant increase was
found in the level of diacyl PE [Fig 6]. The levels of other
species of PE and of all species of PC were comparable in
resting and stimulated T cells. Based on earlier results (see
Fig 5) we conclude that although diacyl PE expanded in
proliferating T cells, the percentage of arachidonate in the
latter fraction (i.e. ~30%) was equivalent in resting and
cycling lymphocytes. In proliferating T cells, enrichment
in AA was observed only in the 1-alkyl-2-acyl and in the 1-
alk-1'enyl-2-acyl fractions of PE, where increases of 1.4
nM/107 cells and 4 nM/107 cells, respectively, were found
[Fig 6].
[3H]AA incorporation into diacyl and plasmalogen species 
of PC and PE
To further define the changes in arachidonoyl phospholi-
pid content that accompany T cell proliferation, the
movement of [3H]AA within individual species of PC and
Incorporation and turnover of [3H] AA within membrane phospholipids of proliferating and resting CD4+ and CD8+ T cells Figure 3
Incorporation and turnover of [3H] AA within membrane phospholipids of proliferating and resting CD4+ and CD8+ T cells. 
Splenic T cells were culture as above for 48 hr with (open symbols) or without (closed symbols) anti-CD3 mAb, then enriched 
for CD4+ T cells (dashed triangles) or CD8+ T cells (circles) by negative selection. Following labeling with [3H]AA (1 µCi/ml) 
for 20 min, the cells were then washed and cultured at 37°C for 60 min in BME with 1% BSA. At the initiation (zero time) and 
conclusion of culture (60 min), cells were harvested, membrane lipids were extracted and free AA and phosphoglycerides 
were resolved by TLC. The concentration of free [3H]AA and of [3H]AA within different phospholipid molecular species was 
measured by liquid scintillation counting. Data are the mean of 2 experiments.Lipids in Health and Disease 2004, 3 http://www.lipidworld.com/content/3/1/1
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PE was investigated. Splenic T cells cultured with and
without anti-CD3 mAb were incubated with [3H]AA for
20 min. The cells were then harvested, washed and recul-
tured for an additional 60 min in BME and 1% BSA. Mem-
brane phospholipids were subsequently extracted,
separated by TLC and individual species of PC and PE
were quantified. In unstimulated cells, over time, signifi-
cant difference in the distribution of [3H]AA was found
only in the diacyl fraction of PC [Fig 7]. This may reflect a
transfer of free AA to lyso PC (see Figure 2). In
proliferating T cells, a loss of [3H]AA in diacyl-PC was
associated with a quantitatively comparable and highly
selective increase of [3H]AA into 1-alk-1'-enyl-2-acyl-PE.
Discussion
The current study compares the incorporation, distribu-
tion and remodeling of AA within membrane phospholi-
pids of resting and activated CD4+ and CD8+ T cells. The
importance of understanding the movement of AA in T
cells inheres in the fact that the AA content within, and the
release of AA from the plasma membranes of lymphocytes
can significantly modulate T cell activation and the signals
provided by T cells for the activation and growth of other
immune cells, including macrophages, neutrophils, B
lymphocytes and other T cells. It should be noted, how-
ever, that the data presented herein reflect the net changes
that occur in the sum of all cell membranes, not just
plasma membranes. As previously described [7], in intact
resting T cells following a short incubation, newly incor-
porated, radiolabeled AA is primarily distributed into PC
or found free in the membrane. Over 60 min, a decrease
in the level of free [3H]AA is accompanied by a compara-
ble increase in the level of [3H]AA-PC. In lymph node T
cells and thymocytes, the main route of incorporation of
AA into diacyl-PC during short incubations is catalyzed by
the sequential reactions of acyl-CoA synthetase and acyl-
CoA:1-acyl-2-lyso-glycerophosphocholine acyl trans-
ferase [7]. In contrast to resting cells, following a brief
exposure to radiolabeled AA, CD4+ and CD8+ T cells acti-
vated by 48 hr of stimulation with anti-CD3 mAb, prefer-
entially incorporate [3H]AA into PI followed by PC and
then PE. Less than 3% of labeled AA is found free in mem-
branes. As was true of resting T cells, the initial incorpora-
tion of radiolabeled AA into the PC and PI pools of
activated T cells presumably involved the sequential activ-
ities of AA-CoA synthetase followed by 1-acyl-2-lyso-glyc-
erophospholipid acyl transferases. During the subsequent
60 min chase in AA-free medium, a decrease in the [3H]AA
AA content within phospholipids of proliferating and unstimulated splenic T cells Figure 4
AA content within phospholipids of proliferating and unstimulated splenic T cells. Splenic T cells, previously cultured as above 
for 48 hours with (open bars) or without (closed bars) anti-CD3 mAb were harvested, phospholipids were isolated by TLC, 
fatty acids were derivatized to methyl esters and arachidonoyl-methyl ester content was determined by gas chromatography. 
Data are the mean and standard error of 4 experiments.Lipids in Health and Disease 2004, 3 http://www.lipidworld.com/content/3/1/1
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AA content within PC and PE molecular species of proliferat- ing and quiescent T cells Figure 5
AA content within PC and PE molecular species of proliferat-
ing and quiescent T cells. Splenic T cells, previously cultured 
as above for 48 hours with (open bars) or without (closed 
bars) anti-CD3 mAb, were harvested and PC and PE species 
were resolved by TLC. Phospholipids were further separated 
into diacyl-, 1-alkyl-2-acyl- and 1-alk-1'enyl-2-acyl-diaglycer-
ides. Fatty acids were derivatized to methyl esters as above 
and arachidonoyl-methyl ester content was determined by 
gas chromatography. Data are the mean and standard error 
of 3 experiments.
A comparison of the content of diacyl- and ether-lipids  within PC and PE species of proliferating and unstimulated T  cells Figure 6
A comparison of the content of diacyl- and ether-lipids 
within PC and PE species of proliferating and unstimulated T 
cells. Splenic T cells pooled from 4 mice, previously cultured 
as above for 48 hours with (open bars) or without (closed 
bars) anti-CD3 mAb, were harvested and PC and PE species 
were resolved by TLC. Phospholipids were further separated 
into diacyl-, 1-alkyl-2-acyl- and 1-alk-1'enyl-2-acyl-diaglycer-
ides and the content of diacyl- and ether-lipids was quantified 
by elemental phosphorous measurement. Data are the mean 
and standard error of three experiments.Lipids in Health and Disease 2004, 3 http://www.lipidworld.com/content/3/1/1
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Movement of [3H]AA within PC and PE species of proliferating and unstimulated T cells Figure 7
Movement of [3H]AA within PC and PE species of proliferating and unstimulated T cells. Splenic T cells pooled from 6 mice, 
cultured as above for 48 hr with (open bars) or without (closed bars) anti-CD3 mAb, were labeled with [3H]AA (1 µCi/ml) for 
20 min. The cells were then washed and cultured at 37°C for 60 min in BME with 1% BSA. At the initiation (zero time) and 
conclusion of culture, cells were harvested and PC and PE species were resolved by TLC. Phospholipids were further sepa-
rated into diacyl-, 1-alkyl-2-acyl- and 1-alk-1'enyl-2-acyl-diaglycerides and the content of diacyl- and ether-lipids was quantified 
by liquid scintillation counting. Data are the mean and standard error of 3 experiments. *p < .05 compared to arachidonoyl 
phospholipid content at the initiation of culture. **p < .01 compared to arachidonoyl phospholipid content at the initiation of 
culture.Lipids in Health and Disease 2004, 3 http://www.lipidworld.com/content/3/1/1
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content of PC was observed. The reduction in labeled AA
from PC was accompanied by an equivalent increase in
the [3H]AA content of PE. Further analysis demonstrated
that within the PE pool, all species (i.e. diacyl, alkyl-acyl
and alk-1-enyl-acyl) exhibited an increase in the cold AA
content following T cell activation. However, the percent-
age of AA relative to all fatty acids was increased only in
the alkyl-acyl and 1-alk-1'-enyl-acyl species of PE. Finally,
the loss of [3H]AA within the diacyl-PC fraction of prolif-
erating T cells was accompanied by an equivalent gain in
the level of [3H]AA in 1-alk-1'-enyl-acyl-PE. The data sug-
gest an apparent transfer of AA from the diacyl-PC pool to
the PE plasmalogen pool in proliferating CD4+ and CD8+
T cells. Regardless of AA remodeling, a highly selective net
increase of diacyl-PE content accompanied T cell prolifer-
ation suggesting that de novo diacyl-PE synthesis, or PL
synthesis coupled to head group exchange to yield diacyl-
PE may be an important mechanism turned on by anti-
CD3 mAb.
The mechanism by which AA was putatively transferred
from PC to PE remains speculative. Short term incubation
of alveolar and peritoneal macrophages [26,27] and neu-
trophils [23] with labeled AA is accompanied by a transfer
of esterified AA from diacyl-PC to alkyl-PC and 1-alk-1'-
enyl-acyl-PE. The transfer of AA was shown to exhibit fatty
acid specificity and donor/acceptor specificity resembling
that observed in vitro in the CoA-independent transacyla-
tion system [25]. A similar pattern of labeled AA
movement into 1-ether lipids has been reported in mast
cells [28], platelets [18] and in the brain [29].
As stated earlier, inflammatory cells such as macrophages
and neutrophils contain a high content of ether-phos-
pholipids [15,16]. In such cells, Co-A independent transa-
cylase activity has, under certain conditions been coupled
to the production of platelet activating factor (PAF) and
eicosanoids [30]. PAF, in turn, derives principally from 1-
alkyl-2-arachidonoyl-PC [23]. In contrast, the phospholi-
pid molecular species which serves as a source of AA to be
released or to be utilized for eicosanoid synthesis appears
to depend on cell type. For example, the specific activity of
free AA released from mast cells correlates best with that
of 1-alk-1'-enyl-2-acyl-GPE [31,32], suggesting that AA
may derive from that phospholipid pool, whereas, the
specific activity of released AA in platelets best correlates
with the specific activity of 1-alkyl-2-arachidonoyl-GPC.
Interestingly, AA utilized in leukotriene synthesis in mast
cells appears to emanate not from PE, but rather from PI
or from PC subclasses [31,32]. In neutrophils, AA has a
specific activity in leukotriene B4 that matches AA in 1-
alkyl-2-arachidonoyl-GPC suggesting that it may derive
from that phospholipid [33].
It has been argued that the channeling of AA into ether
phospholipids through the remodeling activity of CoA-
independent transacylase may be necessary for both
eicosanoid production and the synthesis of lipid media-
tors such as PAF. In support of this thesis, pretreatment
with a CoA-independent inhibitor produced a dose-
related decrease in clinical markers of cellular infiltration
(e.g. edema) in an experimental model of inflammation
[34]. It is somewhat more difficult to rationalize a role for
a CoA-independent transacylase system in T cells, which
have a limited capacity to produce PAF and eicosanoids. A
potential explanation is suggested by the finding that a
number of inhibitors of CoA-independent transacylase
induce apoptosis, or programmed cell death in certain cell
lines [35]. One such inhibitor, 1-O-octadecyl-2-O-
methyl-glycero-3-phosphocholine (ET-18-O-CH3), is an
alkyllysophospholipid with known antiproliferative
effects on a variety of transformed cell lines including
those derived from promyelocytes, carcinomas, leukemias
and sarcomas [35-38]. Two additional, structurally dis-
tinct classes of CoA-independent transacylase inhibitors
also induce apoptosis in HL60 cells, which suggests that
disarming the enzyme may lead to programmed cell death
[35]. Inhibition of CoA-independent transacylase activity
in HL60 cells is associated with accumulation of AA in 1-
acyl-2-arachidonoyl-GPC and a loss of arachidonate in 1-
acyl and 1-alk-1'-enyl-2-arachidonoyl-GPE[35]. Based on
these data, it has been postulated that inhibition of CoA-
independent transacylase leads to a failure to appropri-
ately redistribute AA, which in turn predisposes to
apoptosis.
It has been argued that the antiproliferative effect of alkyl-
lysophospholipids is selective in that, while cancer cell
lines are susceptible to ET-18-0-CH3, bone marrow cells,
neutrophils and skin fibroblasts are unaffected by this
CoA-transacylase inhibitor [39]. An alternative explana-
tion is that CoA-independent transacylase inhibitors
preferentially cause cell programmed cell death in rapidly
cycling cells. Viewed in this manner, transformed cells
may undergo apoptosis on exposure to CoA-synthetase
inhibitors simply because they represent one extreme case
of proliferating cells. Conversely, bone marrow cells, neu-
trophils and fibroblasts may resist programmed cell death
because they are either not cycling or are cycling at a rela-
tively slow rate. The therapeutic implications of CoA-
inhibitors, therefore, may transcend their potential use as
oncological agents. Indeed, such inhibitors may have a
therapeutic role in cell-mediated diseases that are orches-
trated by rapidly proliferating lymphocytes cells, such as
rheumatoid arthritis and systemic lupus erythematosus.
Conclusion
In summary, the current study suggests that T cells possess
CoA-independent transacylase activity in vivo, which mayLipids in Health and Disease 2004, 3 http://www.lipidworld.com/content/3/1/1
Page 10 of 12
(page number not for citation purposes)
be responsible for the high plasmalogen content of GPE.
The physiological relevance of this enzyme activity and




Six to 8 week old, male C3H/HeN (H-2k) and Balb/C (H-
2d) mice were obtained from Harlan (Indianapolis, IN).
Materials
Fetal Bovine Serum (FCS) was purchased from Hyclone
Laboratories Inc. (Logan, UT). Eagle's Basal Media (BME),
arachidonic acid, Type XIII phospholipase C, Coomasie
Blue R, triethylamine, Tris (hydroxymethyl)
aminomethane (Tris), EGTA, mannitol phenyl methlysul-
fonyl fluoride (PMSF) and heptadecanoic acid (17:0)
were obtained from Sigma Chemical Co. (St. Louis, MO).
RPMI-1640, L-glutamine, Hepes, and penicillin/strepto-
mycin were purchased from Gibco (Grand Island, NY).
Monoclonal antibodies (mAbs) against CD8 (clone 53-
6.7), CD4 (clone H129.19), and CD3-epsilon (clone 145-
2C11) were obtained from Boehringer Mannheim Bio-
chemicals (Indianapolis, IN). Fluorescein-conjugated
MARK-1, a murine antibody to rat kappa  chains, was
obtained from AMAC, Inc.(Westbrook, ME). Rabbit com-
plement was purchased from Cederlane (Westbury, NY).
Goat anti-mouse Ig was obtained from Tago, Inc.(Burlin-
game, AL). Thymidine, [methyl-3H] ([3H]dTd)(6.7 Ci/
mmol), [5,6,8,9,11,12,14,15,-3H] arachidonic acid
([3H]AA) (76 Ci/mmol), and [choline-methyl-14C] sphin-
gomyelin ([14C] Sph) were purchased from New England
Nuclear (Boston, MA). Lyophilized PC, PS, PI, PE and
phosphatidic acid (PA) were obtained from Avanti Polar
Lipid Co. (Birmingham, AL). Silica gel G TLC plates were
purchased from Analtech Inc. (Newark, DE). The alk-1'-
enyl-2-acyl-glycerol and 1-O-alkyl-2-acyl standards were
obtained by phospholipase C hydrolysis of 1-O-alkyl-2
acyl-sn-glycerol-3-phosphoethanolamine and 1-O-alkyl-
2-acyl-sn-glycerophosphocholine respectively. Phosphol-
ipids were obtained from Serdary Research Laboratories
(London, Ontario, Canada).
Preparation of the cells
Single cell suspensions from the spleens of 4 to 6 mice
were freed of erythrocytes by osmotic lysis. T cell-enriched
preparations were obtained by suspending cells in BME
plus 0.02% NaN3 and 5% FCS and incubating the mixture
on 100 × 15 mm plastic dishes (Falcon Labware, Oxnard,
CA) precoated with 5 µg of anti-mouse Ig at 4°C for 70
min to eliminate B cells. The nonadherent cells were
recovered, washed and the procedure was repeated. The
preparations contained 92–96% Thy-1.2+ cells by immun-
ofluorescence and cytofluorographic analysis, as previ-
ously described [40]. CD4+  T cells and CD8+  T cells
[41,42] were prepared by cytotoxic depletion of T cell-
enriched preparations using anti-CD8 or anti-CD4 mAb,
respectively, as reported earlier [42,43].
Cell proliferation assay
Two × 105 cells (0.2 ml) were optimally stimulated with 5
µg/ml of anti-CD3 mAb in 96 well flat bottom plates
(Costar, Cambridge, MA) for varying periods of time in
medium consisting of RPMI-1640 supplemented with
FCS (5%), L-glutamine (2 mM), penicillin (100 U)/strep-
tomycin (50 mg) and 2-mercaptoethanol (10-5 M). Prolif-
eration was assessed daily for 3 days using tritiated
thymidine incorporation [42].
Incorporation and remodeling of [3H]AA within membrane 
glycerolipids
T cells (107/ml) were incubated in BME at 37°C in a
humidified atmosphere containing 5% CO2 with [3H] AA
(1 µCi/ml) for up to 60 min. After varying periods of time,
duplicate samples containing labeled cells were harvested,
washed and recultured in acid-washed, glass tubes at 107
cells/ml in BME containing 1% BSA, as previously
described [44]. At the conclusion of culture, suspensions
were centrifuged at 400 × g. The supernatant was removed,
cell pellets were washed once in BME then resuspended in
PBS. The suspensions were then spiked with [14C] sphin-
gomyelin (100,000 dpm; 0.9 nmol) to assess recoveries
and membrane lipids were extracted by the method of
Bligh and Dyer [45]. Organic and aqueous phase radioac-
tivities were quantified by liquid scintillation counting.
The organic phase was dried under a stream of nitrogen,
membrane lipids were reconstituted in chloroform/meth-
anol (3:1) and spotted onto Silica gel G plates. The indi-
vidual phospholipid molecular species were resolved by
TLC using a solvent system (number I) consisting of chlo-
roform/methanol/2-propanol/0.25% KCl/ triethylamine
(90:27:75:18:54) [44]. The radioactive glycerolipids were
located on TLC plates using a Bioscan System 200 Imaging
Scanner (Washington DC). Areas corresponding to
authentic Sph (Rf 0.19), PC (Rf 0.22), PS (Rf 0.34), PI (Rf
0.46), PA (Rf 0.50), PE (Rf 0.54), AA (Rf 0.77) and neutral
lipids (Rf 0.86) were scraped from the plate and radioac-
tivity was quantified by liquid scintillation counting.
Quantification of [3H]AA phospholipid molecular species
[3H]AA glycerophospholipids were separated as described
above then scraped and eluted from TLC plates with
methanol/chloroform(2:1). Silica gel was removed by
passage through a empty filtration column with 20 µm
PDVF frits (BAKERBONDspe, J.T. Baker Co.). The eluate
was dried under a stream of nitrogen, reconstituted in
diethylether (2 ml) plus KH2PO4(0.5 M) and incubated
for 60 min at room temperature in the presence of 2 units
(for PC) or 4 units (for PE) of phospholipase C (type XIII)
to generate diglycerides. The ether layer was recovered andLipids in Health and Disease 2004, 3 http://www.lipidworld.com/content/3/1/1
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the aqueous phase was washed twice with diethylether.
After drying under nitrogen, the combined ether layers
were reconstituted in chloroform/methanol (3:1) and
spotted onto Silica gel G plates. Diacyl-, 1-alkyl-2-acyl-
and 1-alk-1'-enyl-2-acyl-diglycerides were resolved by TLC
in a solvent system (number II) consisting of diethylether/
hexane/acetic acid (60:50:0.75). The radioactive diglycer-
ides were localized as described above. Areas corespond-
ing to authentic diacyl-, 1-alkyl-2-acyl- and 1-alk-1'enyl-2-
acyl-diglycerides were scraped from the plate and radioac-
tivity was quantified by liquid scintillation counting.
Quantification of membrane phospholipids
The membrane phospholipid content of T cells was quan-
tified as described earlier [46]. T cells (2.5 × 106/ml) were
suspended in a buffer (pH 7.4) consisting of mannitol
(300 mM), Tris (15 mM), EGTA (5 mM) and PMSF and
the cells were cavitated at 4°C using a cell disruption
bomb (Parr Instrument Co., Moline, IL). The homogenate
was centrifuged at 48,000 × g for 30 min. The supernatant
was discarded and the membrane pellet was resuspended
in cold PBS. Membrane homogenates were spiked with
[14C] sphingomyelin (100,000 dpm) to assess recoveries
and lipids were extracted. Membranes were spotted onto
Silica Gel G plates and lipids were resolved in solvent sys-
tem number I. Areas corresponding to authentic sphingo-
myelin, PC, and PE were scraped and eluted from TLC
plates. To determine overall recoveries, total PC and PE
levels were quantified by elemental phosphorous meas-
urement [47] in an aliquot of eluate. Diglycerides were
generated from the remaining portion of the phospholi-
pid eluates and the diacyl and plasmalogen fractions were
resolved in solvent system number II using Silica Gel G
plates as above. Areas corresponding to authentic stand-
ards were scraped and eluted from the plates, and the dia-
cyl-, 1-alkyl-2-acyl-, and 1-alk-1'enyl-2-acyl contents of
PC and PE were quantified by elemental phosphorous
measurement.
Assessment of the molar concentration of AA within 
phospholipids
The molar concentration of AA within membrane phos-
pholipids was measured as previously described [44].
Lipid extracts were prepared from T cells which had been
cultured for 48 hrs with and without anti-CD3 mAb and
membrane phospholipids were isolated. In some experi-
ments, phospholipids were further separated into diacyl-,
1-alkyl-2-acyl- and 1-alk-1'-enyl-2-acyl-diglycerides. Glyc-
erolipids were scraped from TLC plates, eluted from silica
into chloroform/methanol (2:1) and the silica was
removed by passage through a filtration column. The
remaining silica was washed with chloroform/methanol
(2:1). Lipids were spiked with heptadecanoic acid (17:0)
(10 µg) as an internal standard and dried under a stream
of nitrogen. Fatty acid methyl esters (FAMEs) were made
by heating in 1 ml hydrochloric acid/methanol (10:90) at
100°C for 12 min. Mixtures were cooled then neutralized
using 5 N NaOH (0.5 ml). FAMEs were extracted twice
from the aqueous phase into hexane (1 ml) and the
FAME-hexane was dried under nitrogen. FAMEs were then
resuspended in hexane (50 µl) and resolved from 140 to
220°C using a Hewlet-Packard (Palo Alto, CA) 5890A gas
chromatography system equipped with a DB355 column
(0.25 mm × 30 m) (J&W Scientific, Folsom, CA).
Individual FAMEs were detected by a flame ionization
detector and identified by comparison of Rf of FAME
standards. The quantity of arachidonoyl-methyl ester was
determined relative to the heptadecanoyl-methyl ester
peak area.
Expression of data
Data are expressed as the mean ± SEM. Significance was
defined as a p value of less than .05 using Student's t test.
List of abbreviations
AA, arachidonic acid, PC, phosphatidyl choline, PS phos-
phatidyl serine, PI phosphatidyl inositol, PE  phosphati-
dyl ethanolamine, PA, phosphatidic acid, Sph,
sphingomyelin, GPC, glycerophosphocholine, GPE, glyc-
erophosphoethanolamine, FAMEs, fatty acid methyl
esters.
Author's contributions
MT participated in all of the techniques used in this man-
uscript including preparation of T cell subsets. SA partici-
pated in fatty acid analysis by gas chromatography. RB
gave the technical supports and fatty acid standards
necessary for this study. TS conceived of the study, and
participated in its design and coordination. All authors
read and approved the final manuscript.
References
1. Gill R, Clark W: Membrane structure-function relationships in
cell-mediated cytolysis. I. Effect of exogenously incorporated
fatty acids on effector cell function in cell-mediated cytolysis.
J Immunol 1980, 125:689-695.
2. Overath P, Schairer HU, Stoffel W: Correlation of in vivo and in
vitro phase transitions of membrane lipids in Escherichia
coli. Proc Natl Acad Sci U S A 1970, 67:606-612.
3. Goetzl EJ: Mediators of immediate hypersensitivity derived
from arachidonic acid. N Engl J Med 1980, 303:822-825.
4. Winkler JD, Sung CM, Huang L, Chilton FH: CoA-independent
transacylase activity is increased in human neutrophils after
treatment with tumor necrosis factor alpha. Biochim Biophys
Acta 1994, 1215:133-140.
5. Sekiguchi K, Tsukuda M, Ogita K, Kikkawa U, Nishizuka Y: Three
distinct forms of rat brain protein kinase C: differential
response to unsaturated fatty acids.  Biochem Biophys Res
Commun 1987, 145:797-802.
6. Kelly JP, Parker CW: Effects of arachidonic acid and other
unsaturated fatty acids on mitogenesis in human
lymphocytes. J Immunol 1979, 122:1556-1562.
7. Trotter J, Flesch I, Schmidt B, Ferber E: Acyltransferase-catalyzed
cleavage of arachidonic acid from phospholipids and transfer
to lysophosphatides in lymphocytes and macrophages. J Biol
Chem 1982, 257:1816-1823.Lipids in Health and Disease 2004, 3 http://www.lipidworld.com/content/3/1/1
Page 12 of 12
(page number not for citation purposes)
8. Yamashita A, Sugiura T, Waku K: Acyltransferases and transacy-
lases involved in fatty acid remodeling of phospholipids and
metabolism of bioactive lipids in mammalian cells. J Biochem
(Tokyo) 1997, 122:1-16.
9. Balsinde J, Bianco ID, Ackermann EJ, Conde-Frieboes K, Dennis EA:
Inhibition of calcium-independent phospholipase A2 pre-
vents arachidonic acid incorporation and phospholipid
remodeling in P388D1 macrophages. Proc Natl Acad Sci U S A
1995, 92:8527-8531.
10. Reynolds LJ, Hughes LL, Louis AI, Kramer RM, Dennis EA: Metal ion
and salt effects on the phospholipase A2, lysophospholipase,
and transacylase activities of human cytosolic phospholipase
A2. Biochim Biophys Acta 1993, 1167:272-280.
11. Irvine RF, Dawson RM: Transfer of arachidonic acid between
phospholipids in rat liver microsomes.  Biochem Biophys Res
Commun 1979, 91:1399-1405.
12. Sugiura T, Masuzawa Y, Waku K: Coenzyme A-dependent
transacylation system in rabbit liver microsomes. J Biol Chem
1988, 263:17490-17498.
13. Sugiura T, Kudo N, Ojima T, Mabuchi-Itoh K, Yamashita A, Waku K:
Coenzyme A-dependent cleavage of membrane phospholip-
ids in several rat tissues: ATP-independent acyl-CoA synthe-
sis and the generation of lysophospholipids. Biochim Biophys Acta
1995, 1255:167-176.
14. Sugiura T, Kudo N, Ojima T, Kondo S, Yamashita A, Waku K: Coen-
zyme A-dependent modification of fatty acyl chains of rat
liver membrane phospholipids: possible involvement of
ATP-independent acyl- CoA synthesis.  J Lipid Res 1995,
36:440-450.
15. Sugiura T, Masuzawa Y, Waku K: Transacylation of 1-O-alkyl-SN-
glycero-3-phosphocholine (lyso platelet- activating factor)
and 1-O-alkenyl-SN-glycero-3-phosphoethanolamine with
docosahexaenoic acid (22:6 omega 3).  Biochem Biophys Res
Commun 1985, 133:574-580.
16. Chilton FH, Hadley JS, Murphy RC: Incorporation of arachidonic
acid into 1-acyl-2-lyso-sn-glycero-3- phosphocholine of the
human neutrophil. Biochim Biophys Acta 1987, 917:48-56.
17. Sugiura T, Masuzawa Y, Nakagawa Y, Waku K: Transacylation of
lyso platelet-activating factor and other lysophospholipids by
macrophage microsomes. Distinct donor and acceptor
selectivities. J Biol Chem 1987, 262:1199-1205.
18. Kramer RM, Deykin D: Arachidonoyl transacylase in human
platelets. Coenzyme A-independent transfer of arachido-
nate from phosphatidylcholine to
lysoplasmenylethanolamine. J Biol Chem 1983, 258:13806-13811.
19. Sugiura T, Masuzawa Y, Waku K: Alkenyl and alkyl ether phos-
pholipids in pig mesenteric lymph node lymphocytes. Lipids
1980, 15:475-478.
20. Sugiura T, Katayama O, Fukui J, Nakagawa Y, Waku K: Mobilization
of arachidonic acid between diacyl and ether phospholipids
in rabbit alveolar macrophages. FEBS Lett 1984, 165:273-276.
21. Mueller HW, O'Flaherty JT, Greene DG, Samuel MP, Wykle RL: 1-O-
alkyl-linked glycerophospholipids of human neutrophils: dis-
tribution of arachidonate and other acyl residues in the
ether- linked and diacyl species. J Lipid Res 1984, 25:383-388.
22. Yoshioka S, Nakashima S, Okano Y, Hasegawa H, Ichiyama A, Nozawa
Y: Phospholipid (diacyl, alkylacyl, alkenylacyl) and fatty acyl
chain composition in murine mastocytoma cells. J Lipid Res
1985, 26:1134-1141.
23. Chilton FH, Murphy RC: Remodeling of arachidonate-contain-
ing phosphoglycerides within the human neutrophil.  J Biol
Chem 1986, 261:7771-7777.
24. Nakamura T, Fonteh AN, Hubbard WC, Triggiani M, Inagaki N,
Ishizaka T, Chilton FH: Arachidonic acid metabolism during
antigen and ionophore activation of the mouse bone marrow
derived mast cell. Biochim Biophys Acta 1991, 1085:191-200.
25. Chilton FH, Fonteh AN, Surette ME, Triggiani M, Winkler JD: Con-
trol of arachidonate levels within inflammatory cells. Biochim
Biophys Acta 1996, 1299:1-15.
26. Balsinde J, Fernandez B, Solis-Herruzo JA: Increased incorporation
of arachidonic acid into phospholipids in zymosan-stimu-
lated mouse peritoneal macrophages.  Eur J Biochem 1994,
221:1013-1018.
27. Triggiani M, Oriente A, Marone G: Differential roles for triglycer-
ide and phospholipid pools of arachidonic acid in human lung
macrophages. J Immunol 1994, 152:1394-1403.
28. Fonteh AN, Chilton FH: Rapid remodeling of arachidonate
from phosphatidylcholine to phosphatidylethanolamine
pools during mast cell activation.  J Immunol 1992,
148:1784-1791.
29. Masuzawa Y, Sugiura T, Sprecher H, Waku K: Selective acyl trans-
fer in the reacylation of brain glycerophospholipids. Com-
parison of three acylation systems for 1-alk- 1'-enylglycero-3-
phosphoethanolamine, 1-acylglycero-3- phosphoeth-
anolamine and 1-acylglycero-3-phosphocholine in rat brain
microsomes. Biochim Biophys Acta 1989, 1005:1-12.
30. Sugiura T, Fukuda T, Masuzawa Y, Waku K: Ether lysophospholi-
pid-induced production of platelet-activating factor in
human polymorphonuclear leukocytes.  Biochim Biophys Acta
1990, 1047:223-232.
31. Fonteh AN, Chilton FH: Mobilization of different arachidonate
pools and their roles in the generation of leukotrienes and
free arachidonic acid during immunologic activation of mast
cells. J Immunol 1993, 150:563-570.
32. Fonteh AN, Bass DA, Marshall LA, Seeds M, Samet JM, Chilton FH:
Evidence that secretory phospholipase A2 plays a role in ara-
chidonic acid release and eicosanoid biosynthesis by mast
cells. J Immunol 1994, 152:5438-5446.
33. Colard O, Breton M, Pepin D, Chevy F, Bereziat G, Polonovski J: Ara-
chidonate cannot be released directly from diacyl-sn-glyc-
ero-3- phosphocholine in thrombin-stimulated platelets.
Biochem J 1989, 259:333-339.
34. Winkler JD, Fonteh AN, Sung CM, Heravi JD, Nixon AB, Chabot-
Fletcher M, Griswold D, Marshall LA, Chilton FH: Effects of CoA-
independent transacylase inhibitors on the production of
lipid inflammatory mediators.  J Pharmacol Exp Ther 1995,
274:1338-1347.
35. Surette ME, Winkler JD, Fonteh AN, Chilton FH: Relationship
between arachidonate--phospholipid remodeling and
apoptosis. Biochemistry 1996, 35:9187-9196.
36. Modolell M, Andreesen R, Pahlke W, Brugger U, Munder PG: Distur-
bance of phospholipid metabolism during the selective
destruction of tumor cells induced by alkyl-lysophospholip-
ids. Cancer Res 1979, 39:4681-4686.
37. Berdel WE, Bausert WR, Fink U, Rastetter J, Munder PG: Anti-
tumor action of alkyl-lysophospholipids (Review). Anticancer
Res 1981, 1:345-352.
38. Hoffman DR, Hajdu J, Snyder F: Cytotoxicity of platelet activat-
ing factor and related alkyl- phospholipid analogs in human
leukemia cells, polymorphonuclear neutrophils, and skin
fibroblasts. Blood 1984, 63:545-552.
39. Chilton FH, Surette ME, Winkler JD: Arachidonate-phospholipid
remodeling and cell proliferation.  Adv Exp Med Biol 1996,
416:169-172.
40. Santoro TJ, Portanova JP, Kotzin BL: The contribution of L3T4+
T cells to lymphoproliferation and autoantibody production
in MRL-lpr/lpr mice. J Exp Med 1988, 167:1713-1718.
41. Santoro TJ, Lehmann KR, Batt RA, Kotzin BL: The role of L3T4+
cells in the pathogenesis of lupus in lpr-bearing mice. I.
Defects in the production of interleukins 2 and 3. Eur J Immunol
1987, 17:1131-1136.
42. Tomita M, Irwin KI, Xie Z-J, Santoro TJ: Tea pigments inhibit the
production of type1 (TH1) and type2 (TH2) helper T cell
cytokines in CD4+ T cells. Phytotherapy Research 2001.
43. Tomita-Yamaguchi M, Rubio C, Santoro TJ: Regional influences on
the physical properties of T cell membranes. Life Sci 1991,
48:433-438.
44. Tomita-Yamaguchi M, Babich JF, Baker RC, Santoro TJ: Incorpora-
tion, distribution, and turnover of arachidonic acid within
membrane phospholipids of B220+ T cells from autoim-
mune-prone MRL- lpr/lpr mice. J Exp Med 1990, 171:787-800.
45. Bligh EG, Dyer WJ: A rapid method of total lipid extraction and
purification. Can J Biochem Physiol 1959, 37:911-917.
46. Tomita-Yamaguchi M, Santoro TJ: Constitutive turnover of inosi-
tol-containing phospholipids in B220+ T cells from autoim-
mune-prone MRL-lpr/lpr mice. J Immunol 1990, 144:3946-3952.
47. Rouser G, Siakotos AN, Fleischer S: Quantitative analysis of
phospholipids by thin-layer chromatography and phospho-
rous analysis of spots. Lipids 1966, 1:85.